> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# InfuTronix Recalls Malfunctioning Infusion Pumps
- URL: https://www.fdaweb.com/infutronix-recalls-malfunctioning-infusion-pumps/
- Published: 2024-04-25T12:00:00.000Z
- Updated: 2026-09-14T14:29:08.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5156848

InfuTronix has recalled (Class 1) its Nimbus infusion pump systems due to multiple potential failure modes that may include battery failure, upstream blockage (occlusion), system errors, drug product leakage, high or low flow rate, or damaged housing. According to a [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/infutronix-llc-recalls-nimbus-and-nimbus-ii-infusion-pump-systems-multiple-device-failures-may-cause?utm%5Fmedium=email&utm%5Fsource=govdelivery), the devices will not be available or supported after 6/20.

“Using affected pumps could cause infection from microbial contamination after loss of the sterile barrier (leakage)," the notice says, adding that "interruptions or delays in therapy from unnoticed occlusion may lead to underdosing of vital medications and fluids resulting in uncontrolled hypertension (high blood pressure), dehydration (water loss), and electrolyte imbalance; seizures, shock and organ failure may occur." It says use of the products may lead to serious injury or death.

To date, InfuTronix has received 3,698 complaints, six serious injuries, and one death related to the issue.